Research & Publications


The Institute of Eye Surgery (In collaboration with EyeLab) engages in world class ocular research and attracts the very best academic research talent that Ireland currently has to offer. EyeLab is a commercial entity involved in the procurement and exploitation of funding for ophthalmic innovations and research. Collectively, IoES specialists have published over 300 peer reviewed journal articles in leading eye publications, further advancing our knowledge and understanding of complex eye disease and therapeutics. IoES has also filed numerous technology patents and successfully spunout and exited the intellectual property rights of a multi-million euro granted cataract biometric device.

Recent R&D projects and academic publications  (With links to abstract articles) are listed below:


OD-OS GmbH: 2020-present 

Research Sites: International 

Remit: To assess the long-term safety and efficacy of navigated 577nm laser (Navilas) for the  management of diabetic macular edema, central serous chorioretinopathy, retinal vein  occlusion, proliferative diabetic retinopathy and laser retinopexy.

Carl Zeiss Meditec GmbH: 2020-present 

Research Site: Institute of Eye Surgery, Ireland. 

Remit: To assess the long-term safety and efficacy of Nd:YAG laser vitreolysis for managing  vitreous floaters with the Visulas YAG III laser.

Bayer GmbH, Alcedis: 2019-present 

Research Sites: International. 

Remit: XTEND Phase 4 trial to examine the effectiveness of proactive treatment regimens of  intravitreal aflibercept in treatment-naïve patients with wet age-related macular degeneration.

Allergan, Syneos Health: 2019-present 

Research Sites: International. 

Co-Investigators: J Astalos, Institute of Eye Surgery, Ireland. 

Remit: TRITON Phase 3 trial of bimatoprost sustain release anterior chamber implant for  chronic open angle glaucoma.

Ebiga Vision, Waterford Institute of Technology, 2017-present  

Research Site: Nutrition Research Centre Ireland, Waterford, Ireland.  

Co-Investigators: J Nolan, Waterford Institute of Technology, Ireland. 

Remit: Recruit, manage, collect data and analyse quality of life impact of vitreous floaters and  their correlation to a novel biomarker.

Alcon UK & Ireland, 2016-present 

Development Site: Institute of Eye Surgery, Waterford, Ireland. 

Remit: Medical device trialling, product launch specialist, medical advisory board member.  Multiple EMEA Clareon®Autonomelaunch contracts, launched Digitally Assisted Cataract  Surgery (DACS) with NGenuity®.

Santen Jpn, ICON Irl, 2017-2019 

Research Sites: International. 

Co-Investigators: J Traynor, Cork, Ireland. 

Remit: National coordinating investigator for Ireland: Recruit, manage and remotely link post marketing data for real world efficacy of tafluprost timolol combination in the treatment of  primary open angle glaucoma and ocular hypertension.

Novartis AG, IMS Health GmBH, 2016-2019 

Research Sites: International (53 in USA, 5 in UK, 4 in Australia, 2 in Ireland). Remit: VERO study- Recruit, manage and remotely link post-marketing data for real  world anti-VEGF injection clinical data.

Roche AG, 2016-2017 

Research Sites: International (4 in UK, 2 in Germany, 1 in Ireland). 

Co-Investigators: P Patel, Moorfields Eye Hospital, London. 

Remit: Recruit, manage, collect data and analyse burden of illness study for geographic  atrophy.

SIFI Medtech Srl, 2014-2018 

Research Sites: Institute of Eye Surgery, Waterford, Ireland & Vision Breteuil, Paris, France Co-Investigators: D Pietrini 

Remit: Recruit, manage, analyse and present post-marketing data for novel multifocal  intraocular lens implant platform.

CMG Training, 2016 

Remit: Consultant to training courses.

Medeuronet SAS, 2014-2016 

Remit: Consultant for cataract and retinal projects.